High-Dose Aumolertinib Combined Intrathecal Chemotherapy for LM from EGFR-Mutated NSCLC with Meningeal Symptoms as the First Symptom

被引：0
|
作者：
Wang, W. [1 ,2 ]
Fan, S. B. [1 ]
Huang, X. P. [1 ]
Zhong, M. X. [1 ]
Guo, J. [1 ]
机构：
[1] Chongqing Univ Three Gorges Hosp, Ctr Canc, Chongqing, Peoples R China
[2] Chongqing Municipal Clin Res Ctr Geriatr Dis, Chongqing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
aumolertinib; intrathecal chemotherapy; leptomeningeal metastasis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-24
引用
收藏
页码：S650 / S650
页数：1
相关论文
共 50 条
  • [41] Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?
    Tanaka, Tomohiro
    Ishiki, Hiroto
    Kubo, Emi
    Yokota, Sayuri
    Shimizu, Masaki
    Kiuchi, Daisuke
    Satomi, Eriko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (08) : 843 - +
  • [42] Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data from FLAURA2
    Lee, C. K.
    Robichaux, J. P.
    Janne, P. A.
    Kim, S-W.
    Kim, T. M.
    Kobayashi, K.
    Planchard, D.
    Sugawara, S.
    Yanagitani, N.
    Yang, T-Y.
    Markovets, A.
    Bhetaryia, P.
    Poole, L.
    Rukazenkov, Y.
    Hartmaier, R. J.
    Yang, J. C-H.
    ANNALS OF ONCOLOGY, 2023, 34 : S1669 - S1670
  • [43] Combined surgery, sequential double high-dose chemotherapy with autologous peripheral stem cell transplantation and intrathecal radiopeptide brachytherapy for relapsed medulloblastoma of the cauda
    Sidler, M
    Avoledo, P
    Gratwohl, A
    Merlo, A
    Kühne, T
    BONE MARROW TRANSPLANTATION, 2002, 29 : S190 - S190
  • [44] Dose escalation results from a first-in-human, phase I/II study of GB263T, a novel EGFR/cMET/cMET trispecific antibody, in patients with advanced EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC)
    Yang, Jin-Ji
    Pavlakis, Nick
    Xie, Fan
    Li, Tong
    Wu, Yi-Long
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [45] HIGH-DOSE INTRAARTERIAL PLUS INTRAPERITONEAL CHEMOTHERAPY COMBINED WITH HEMOFILTRATION IN LIVER METASTASES FROM COLORECTAL-CANCER
    DAZZI, C
    FIORENTINI, G
    DAVITTI, B
    PRIORI, T
    CANTORE, M
    PODDIE, D
    CAROSI, V
    MARANGOLO, M
    ALBIZI, SD
    CRUCIANI, G
    TUMORI, 1994, 80 (03) : 204 - 208
  • [46] Preliminary dose escalation results from a first-in-human, phase I/II study of GB263T, a novel EGFR/cMET/cMET trispecific antibody, in patients with advanced EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC)
    Yang, Jin-Ji
    Pavlakis, Nick
    Xie, Fan
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients
    Ferreri, AJM
    Reni, M
    Dell'Oro, S
    Ciceri, F
    Bernardi, M
    Camba, L
    Ponzoni, M
    Terreni, MR
    Tomirotti, M
    Spina, M
    Villa, E
    ONCOLOGY, 2001, 60 (02) : 134 - 140
  • [48] Irinotecan combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced gastric carcinoma as the first-line chemotherapy
    Yilmaz, Ugur
    Oztop, Iihan
    Alacacioglu, Ahmet
    Yaren, Arzu
    Tarhan, Oktay
    Somali, Isil
    CHEMOTHERAPY, 2006, 52 (05) : 264 - 270
  • [49] First-in-human study of ABBV-637, an EGFR-targeting BCL-XL-inhibiting antibody-drug conjugate combined with osimertinib (OSI) in relapsed/refractory, EGFR-mutated non-small cell lung cancer (NSCLC)
    Rotow, J. K.
    Waqar, S. N.
    Papadopoulos, K. P.
    Hung, J-Y.
    Spira, A. I.
    Gan, H.
    Yoshida, T.
    Kuo, C-H. S.
    Doger de Speville, B.
    Felip, E.
    Yoh, K.
    Morrison-Thiele, G.
    Robinson, R.
    Rudraganguly, N.
    Saab, R.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2023, 34
  • [50] First-line (1L) osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) for EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC): FLAURA2 Asian cohort
    Yang, J. C-H.
    Kobayashi, K.
    Chewaskulyong, B.
    Tran, T. V.
    Biswas, B.
    Lee, K. H.
    Feng, P-H.
    Pham, X. D.
    Yao, Y.
    Kuyama, S.
    Bing, J. Y. Tan Chun
    Bhise, R.
    Ahn, M-J.
    Sriuranpong, V.
    Li, R. K.
    Monterroso, E. Armenteros
    Barrett, K.
    Albayaty, M.
    Cheng, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S1635 - S1636
12345